(GBX) Greenbrier Companies - Overview
Stock: Railcars, Leasing, Maintenance, Manufacturing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.78% |
| Yield on Cost 5y | 3.48% |
| Yield CAGR 5y | 3.93% |
| Payout Consistency | 70.4% |
| Payout Ratio | 21.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.1% |
| Relative Tail Risk | -12.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -30.15 |
| Character TTM | |
|---|---|
| Beta | 1.008 |
| Beta Downside | 1.071 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.69% |
| CAGR/Max DD | 0.60 |
Description: GBX Greenbrier Companies January 14, 2026
The Greenbrier Companies (GBX) designs, manufactures, and markets a full range of railroad freight-car equipment across North America, Europe, and South America, operating through two primary segments: Manufacturing and Leasing & Management Services. The Manufacturing segment produces covered hopper cars, gondolas, boxcars, tank cars, intermodal railcars, and related components, while also offering wheel-axle reconditioning, machining, and a railcar-maintenance network. The Leasing & Management Services segment provides operating and per-diem leases for roughly 17,000 railcars and delivers comprehensive fleet-management, accounting, and re-marketing services to railroads, shippers, leasing firms, and institutional investors.
Key quantitative indicators (FY 2023) include approximately $2.5 billion in revenue, an operating margin near 6 %, and an order backlog of roughly $1.2 billion, reflecting the capital-intensive nature of rail-car procurement. The business is highly sensitive to macro-economic drivers such as North American freight-volume growth (historically 1-3 % YoY) and infrastructure-spending cycles, which together influence demand for new and refurbished railcars. A sector-wide trend toward “sustainable conversions”-retro-fitting existing cars for lower emissions-offers a potential upside as regulators and shippers prioritize greener logistics.
For a deeper quantitative assessment of GBX’s valuation metrics, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 185.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 4.57 > 1.0 |
| NWC/Revenue: 35.47% < 20% (prev 17.76%; Δ 17.71% < -1%) |
| CFO/TA 0.09 > 3% & CFO 402.2m > Net Income 185.2m |
| Net Debt (1.49b) to EBITDA (465.7m): 3.19 < 3 |
| Current Ratio: 3.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.9m) vs 12m ago -1.11% < -2% |
| Gross Margin: 17.34% > 18% (prev 0.17%; Δ 1717 % > 0.5%) |
| Asset Turnover: 71.41% > 50% (prev 84.11%; Δ -12.70% > 0%) |
| Interest Coverage Ratio: 3.87 > 6 (EBITDA TTM 465.7m / Interest Expense TTM 88.1m) |
Altman Z'' 3.61
| A: 0.25 (Total Current Assets 1.58b - Total Current Liabilities 496.3m) / Total Assets 4.30b |
| B: 0.29 (Retained Earnings 1.23b / Total Assets 4.30b) |
| C: 0.08 (EBIT TTM 340.9m / Avg Total Assets 4.29b) |
| D: 0.47 (Book Value of Equity 1.20b / Total Liabilities 2.56b) |
| Altman-Z'' Score: 3.61 = AA |
Beneish M -0.78
| DSRI: 1.02 (Receivables 527.7m/609.7m, Revenue 3.06b/3.61b) |
| GMI: 0.97 (GM 17.34% / 16.79%) |
| AQI: 5.08 (AQ_t 0.46 / AQ_t-1 0.09) |
| SGI: 0.85 (Revenue 3.06b / 3.61b) |
| TATA: -0.05 (NI 185.2m - CFO 402.2m) / TA 4.30b) |
| Beneish M-Score: -0.78 (Cap -4..+1) = D |
What is the price of GBX shares?
Over the past week, the price has changed by +6.35%, over one month by +3.01%, over three months by +28.41% and over the past year by -12.90%.
Is GBX a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the GBX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.7 | -9% |
| Analysts Target Price | 49.7 | -9% |
| ValueRay Target Price | 62.8 | 14.9% |
GBX Fundamental Data Overview February 02, 2026
P/E Forward = 11.0619
P/S = 0.5122
P/B = 1.0006
P/EG = 1.93
Revenue TTM = 3.06b USD
EBIT TTM = 340.9m USD
EBITDA TTM = 465.7m USD
Long Term Debt = 1.77b USD (from longTermDebt, last quarter)
Short Term Debt = 399.0m USD (from shortTermDebt, last quarter)
Debt = 1.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.49b USD (from netDebt column, last quarter)
Enterprise Value = 3.06b USD (1.57b + Debt 1.85b - CCE 361.8m)
Interest Coverage Ratio = 3.87 (Ebit TTM 340.9m / Interest Expense TTM 88.1m)
EV/FCF = 24.78x (Enterprise Value 3.06b / FCF TTM 123.4m)
FCF Yield = 4.03% (FCF TTM 123.4m / Enterprise Value 3.06b)
FCF Margin = 4.03% (FCF TTM 123.4m / Revenue TTM 3.06b)
Net Margin = 6.04% (Net Income TTM 185.2m / Revenue TTM 3.06b)
Gross Margin = 17.34% ((Revenue TTM 3.06b - Cost of Revenue TTM 2.53b) / Revenue TTM)
Gross Margin QoQ = 14.63% (prev 18.51%)
Tobins Q-Ratio = 0.71 (Enterprise Value 3.06b / Total Assets 4.30b)
Interest Expense / Debt = 0.89% (Interest Expense 16.4m / Debt 1.85b)
Taxrate = 24.80% (12.3m / 49.6m)
NOPAT = 256.4m (EBIT 340.9m * (1 - 24.80%))
Current Ratio = 3.19 (Total Current Assets 1.58b / Total Current Liabilities 496.3m)
Debt / Equity = 1.20 (Debt 1.85b / totalStockholderEquity, last quarter 1.54b)
Debt / EBITDA = 3.19 (Net Debt 1.49b / EBITDA 465.7m)
Debt / FCF = 12.04 (Net Debt 1.49b / FCF TTM 123.4m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.32% (Net Income 185.2m / Total Assets 4.30b)
RoE = 12.27% (Net Income TTM 185.2m / Total Stockholder Equity 1.51b)
RoCE = 10.41% (EBIT 340.9m / Capital Employed (Equity 1.51b + L.T.Debt 1.77b))
RoIC = 7.84% (NOPAT 256.4m / Invested Capital 3.27b)
WACC = 4.79% (E(1.57b)/V(3.42b) * Re(9.63%) + D(1.85b)/V(3.42b) * Rd(0.89%) * (1-Tc(0.25)))
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.41%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈123.4m ; Y1≈81.0m ; Y5≈37.0m
Fair Price DCF = N/A (negative equity: EV 1.18b - Net Debt 1.49b = -307.9m; debt exceeds intrinsic value)
EPS Correlation: 68.74 | EPS CAGR: 34.04% | SUE: -0.40 | # QB: 0
Revenue Correlation: -17.64 | Revenue CAGR: 0.90% | SUE: 0.73 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.93 | Chg30d=-0.167 | Revisions Net=-2 | Analysts=3
EPS current Year (2026-08-31): EPS=4.12 | Chg30d=+0.067 | Revisions Net=+2 | Growth EPS=-37.5% | Growth Revenue=-10.6%
EPS next Year (2027-08-31): EPS=4.48 | Chg30d=-0.092 | Revisions Net=+0 | Growth EPS=+8.9% | Growth Revenue=+1.6%